Park Medi World Q1FY27: Profit up 35%, revenue 19%

Key takeaway from the June quarter

Park Medi World Limited reported strong financial results for the quarter ended June 30, 2026 (Q1FY27), supported by higher patient volumes and improved operating efficiency. Net profit rose faster than operating profit, while margins expanded modestly at the EBITDA level and more sharply at the PAT level. The company also made its management commentary available to investors by publishing the audio of its earnings conference call held on August 4, 2026.

The quarter matters for investors tracking hospital operators because it combines two important signals: growth in revenue and a meaningful improvement in profitability. Park Medi World’s numbers also indicate that scale-up initiatives and operational levers are translating into higher earnings conversion.

Earnings conference call audio released under SEBI rules

Park Medi World said it has published the audio recording of its earnings conference call in the investor relations section of its official website. The call took place on August 4, 2026, and reviewed the company’s unaudited standalone and consolidated financial results for Q1FY27. The disclosure was made under Regulation 30 of the SEBI Listing Regulations.

For market participants, such filings are useful because they provide direct management commentary and a structured Q and A with analysts. While the company did not provide a separate transcript in the provided details, the audio availability improves access to management’s explanation of the quarter’s performance and strategic updates.

Q1FY27 revenue rises 19% on volume growth

Revenue from operations increased 19% year-on-year to ₹475.7 crore in Q1FY27, compared with about ₹398.8 crore to ₹400.0 crore in Q1FY26 (as reported across the company’s disclosures). The company attributed performance to strong patient volume growth and improved operational efficiency.

The same revenue figure was also presented as ₹4,757 million for Q1FY27, which is consistent with ₹475.7 crore when converted into a single base unit. The company’s communication described this as the highest quarterly revenue in its recent history, indicating sustained demand and ramp-up across facilities.

EBITDA up 20% and margin improves to 26.5%

EBITDA (excluding other income) rose 20% year-on-year to ₹126.1 crore in Q1FY27 from about ₹104.9 crore to ₹105.0 crore in Q1FY26. The EBITDA margin improved by 20 basis points to 26.5% from 26.3% in the year-ago quarter.

This margin movement suggests operating leverage, but the improvement is incremental rather than sharp. The company also disclosed that operating profit before depreciation, interest, and tax (excluding other income) at ₹126.09 crore in Q1FY27 was marginally below ₹127.37 crore recorded in Q4FY26, indicating a relatively stable operating run-rate on a quarter-on-quarter basis.

Net profit jumps 35% and PAT margin expands 220 bps

Net profit (PAT) increased 35% year-on-year to about ₹88.6 crore to ₹89.0 crore in Q1FY27, from about ₹65.5 crore to ₹66.0 crore in Q1FY26. PAT margin improved to 18.6% from 16.4%, an expansion of 220 basis points.

The faster growth in PAT versus EBITDA indicates improved earnings conversion during the quarter. The company also reported earnings per share (EPS) of ₹2.05, up 20% from ₹1.70 in Q1FY26.

Consolidated and standalone results covered in the review

Park Medi World stated that the earnings call and the published recording covered both unaudited standalone and consolidated financial results for Q1FY27. In its broader performance summary, the company highlighted revenue growth of 19% to ₹475.7 crore and net profit growth of 35% to ₹88.6 crore, along with the EBITDA margin of 26.5% and PAT margin of 18.6%.

The company also referenced commissioning of new facilities and strategic acquisitions as factors supporting revenue growth. These points were presented alongside operational efficiency and patient volume growth as key drivers for the quarter.

Capacity expansion plans: 1,490 beds in calendar 2026

Alongside the quarterly performance, Park Medi World announced what it described as its largest-ever annual capacity expansion plan. The company expects to add 1,490 new beds during calendar year 2026 through new hospitals, acquisitions, and capacity expansion.

The plan includes an already commissioned 360-bed Agra facility and an upcoming 200-bed Narela hospital. Park Medi World said the proposed additions would represent about 46% growth over its 2025 capacity base of 3,250 beds. Separately, the company also disclosed that bed capacity expanded 32% to 3,960, reflecting a broader scale-up underway.

Summary table: financial performance and disclosure details

Market impact: what the numbers indicate

The reported growth rates point to strong operating momentum in Q1FY27, with revenue up 19% and EBITDA up 20%. The 20 bps expansion in EBITDA margin indicates modest improvement in operational efficiency, while the 220 bps improvement in PAT margin suggests the quarter benefited from better profitability below the EBITDA line as well.

For investors, the combination of rising patient volumes, scaling bed capacity, and consistent operating margins is typically watched closely in the hospital sector. The disclosure that Q1FY27 EBITDA was marginally below Q4FY26 levels also helps frame near-term operating stability, even as the year-on-year trend remained positive.

Analysis: why the earnings call recording matters

Publishing the earnings call audio provides an additional layer of transparency for stakeholders. It enables investors to evaluate how management explains performance drivers such as volumes and efficiency, and how it frames capacity additions like Agra and Narela within the wider 2026 expansion plan.

The expansion plan, including 1,490 beds targeted for calendar 2026, is sizeable relative to the 2025 base capacity of 3,250 beds, as cited by the company. In hospital operations, scaling at this pace can influence utilisation, staffing, and cost structures, making management commentary a valuable input for tracking execution.

Conclusion and next checkpoints for investors

Park Medi World’s Q1FY27 results showed 19% growth in revenue from operations to ₹475.7 crore and 35% growth in net profit to about ₹88.6 to ₹89.0 crore, alongside margin expansion at both EBITDA and PAT levels. The company has also made its earnings call audio publicly accessible through its investor relations website section under SEBI disclosure requirements.

Investors tracking upcoming developments may focus on progress toward the calendar 2026 plan to add 1,490 beds, including ramp-up at the commissioned Agra facility and updates on the upcoming Narela hospital, as discussed in the earnings call.